Truus Janse-de Hoog studied organic chemistry and pharmacy in Amsterdam and Leiden. She specialized in hospital pharmacy and worked for 10 years as pharmacist in several hospitals, the last 6 years as head of the pharmacy. She joined the Registration Department of the Medicines Evaluation Board (MEB) in 1989, where she worked as the head of a unit. In the beginning, Truus was mainly involved in national procedures, but in 1995 she was appointed as the Dutch representative in the Mutual Recognition Facilitation Group (MRFG) in 1995. This group was overviewing the Mutual Recognition Procedure. Truus chaired this group twice during the Dutch Presidency. After the review of the pharmaceutical legislation, a new group (the Coordination group) was created, with the mandate to discuss any question (regulatory or scientific) related to procedures where more than one member state is involved, with the exception of the centralized procedure. In this group all 27 EU member states, and Norway, Iceland and Liechtenstein, are represented. This group meets every month for 2-3 days at the EMEA in London. Truus was elected as the first chair of the Coordination group for mutual recognition and decentralized procedure in November 2005. She was re-elected for a second term in November 2008 till November 2011 Her current position at the MEB is as a staff member in the Section Policy, Governance and Regulatory . She frequently represents the MEB in academic and professional settings, in meetings with health professionals, patient groups, and with industry. Truus has made many presentations on regulatory topics, mainly related to European registration procedures, patient information and transparency. She has been a member of the DIA Regional Advisory Council of Europe, the Programme Review Committee (PRC), and served as Programme Co-chair for the EuroMeeting in 2008.